Blueprint Medicines Corp (STU:2L9)
€ 75.64 -2 (-2.58%) Market Cap: 4.88 Bil Enterprise Value: 4.61 Bil PE Ratio: 0 PB Ratio: 16.65 GF Score: 71/100

Blueprint Medicines Corp (STU:2L9) Transcripts

  • 1